Literature DB >> 25156852

RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice.

M C Louwe1, J C Karper2, M R de Vries2, A Y Nossent2, A J N M Bastiaansen2, J W A van der Hoorn3, K Willems van Dijk4, P C N Rensen1, P Steendijk5, J W A Smit6, P H A Quax7.   

Abstract

BACKGROUND: Toll-like receptor-4 (TLR4), a receptor of the innate immune system, is suggested to have detrimental effects on cardiac function after myocardial infarction (MI). RP105 (CD180) is a TLR4 homolog lacking the intracellular signaling domain that competitively inhibits TLR4-signaling. Thus, we hypothesized that RP105 deficiency, by amplifying TLR4 signaling, would lead to aggravated cardiac dysfunction after MI. METHODS AND
RESULTS: First, whole blood from RP105-/- and wild-type (WT) male C57Bl/6N mice was stimulated with LPS, which induced a strong inflammatory TNFα response in RP105-/- mice. Then, baseline heart function was assessed by left ventricular pressure-volume relationships which were not different between RP105-/- and WT mice. Permanent ligation of the left anterior descending coronary artery was performed to induce MI. Infarct sizes were analyzed by (immuno)histology and did not differ. Fifteen days post MI heart function was assessed and RP105-/- mice had significantly higher heart rate (+21%, P<0.01), end systolic volume index (+57%, P<0.05), end systolic pressure (+22%, P<0.05) and lower relaxation time constant tau (-12%, P<0.05), and a tendency for increased end diastolic volume index (+42%, P<0.06), compared to WT mice. In the area adjacent to the infarct zone, compared to the healthy myocardium, levels of RP105, TLR4 and the endogenous TLR4 ligand fibronectin-EDA were increased as well as the number of macrophages, however this was not different between both groups.
CONCLUSION: Deficiency of the endogenous TLR4 inhibitor RP105 leads to an enhanced inflammatory status and more pronounced cardiac dilatation after induction of MI, underscoring the role of the TLR4 pathway in post-infarction remodeling.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Heart function; Myocardial infarction; Pressure–volume loops; RP105; Toll-like receptor 4

Mesh:

Substances:

Year:  2014        PMID: 25156852     DOI: 10.1016/j.ijcard.2014.07.086

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma.

Authors:  Swati Bhattacharyya; Kim S Midwood; Hang Yin; John Varga
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

Review 2.  Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors.

Authors:  Sumra Komal; Nimrah Komal; Ali Mujtaba; Shu-Hui Wang; Li-Rong Zhang; Sheng-Na Han
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

Review 3.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

4.  Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling.

Authors:  Xiaojv Xiong; Yu Liu; Yang Mei; Jianye Peng; Zhiqiang Wang; Bin Kong; Peng Zhong; Liang Xiong; Dajun Quan; Qi Li; Guangji Wang; He Huang
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

5.  RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways.

Authors:  Jun Yang; Chaojun Yang; Jian Yang; Jiawang Ding; Xinxin Li; Qinqin Yu; Xin Guo; Zhixing Fan; Huibo Wang
Journal:  Int J Mol Med       Date:  2018-03-06       Impact factor: 4.101

6.  Myeloid differentiation protein 1 protected myocardial function against high-fat stimulation induced pathological remodelling.

Authors:  Cai-Jie Shen; Bin Kong; Wei Shuai; Yu Liu; Guang-Ji Wang; Min Xu; Jing-Jing Zhao; Jin Fang; Hui Fu; Xiao-Bo Jiang; He Huang
Journal:  J Cell Mol Med       Date:  2019-05-29       Impact factor: 5.310

7.  Paeonol Attenuates Methotrexate-Induced Cardiac Toxicity in Rats by Inhibiting Oxidative Stress and Suppressing TLR4-Induced NF-κB Inflammatory Pathway.

Authors:  Abdulla Y Al-Taher; Mohamed A Morsy; Rehab A Rifaai; Nagwa M Zenhom; Seham A Abdel-Gaber
Journal:  Mediators Inflamm       Date:  2020-02-10       Impact factor: 4.711

Review 8.  The Intriguing Role of TLR Accessory Molecules in Cardiovascular Health and Disease.

Authors:  Taisiya Bezhaeva; Jacco Karper; Paul H A Quax; Margreet R de Vries
Journal:  Front Cardiovasc Med       Date:  2022-02-14

Review 9.  The emerging role of Toll-like receptor 4 in myocardial inflammation.

Authors:  Y Yang; J Lv; S Jiang; Z Ma; D Wang; W Hu; C Deng; C Fan; S Di; Y Sun; W Yi
Journal:  Cell Death Dis       Date:  2016-05-26       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.